The Precision Point Advanced Oxidative Stress Test and the Gut-Ox Stress Test both assess a battery of markers to pinpoint oxidative stress levels and the damage they cause in the body. In addition, the Gut-Ox Stress Test examines the genesis of oxidative stress from gut dysbiosis and intestinal permeability, and its impact on the oxidative system. One important marker measured is F2-isoprostane. While F-2 Isoprostane is a marker of oxidative stress rather than of gut dysbiosis and permeability, oxidative stress can also drive a feedback loop of gut inflammation. Urinary F2-isoprostane is the gold standard marker of lipid peroxidation in biological specimens and has been described as a “reliable approach to assess oxidative stress.”
F-2 Isoprostanes are a group of compounds formed by the non-enzymatic peroxidation of arachidonic acid, a type of fatty acid. They are considered reliable biomarkers of oxidative stress. Measuring F-2 Isoprostanes provides a direct indication of lipid peroxidation, a process in which free radicals attack lipids in cell membranes, leading to cell damage. This measurement is particularly valuable because it reflects the extent of oxidative damage and helps in understanding the progression of diseases associated with oxidative stress, such as cardiovascular diseases, neurodegenerative disorders, and certain cancers.
F2-isoprostane can cause vasoconstriction in the kidneys, lungs, liver, bronchi, blood and lymph vessels, uterus, and gastrointestinal tract. F2-isoprostanes are associated with increased perception of pain and are elevated in acutely hyperglycemic diabetics. They are also high in smokers and in autism.
F2-isoprostane has been suggested as an indicator of cardiovascular disease.F2-isoprostanes were higher in patients with coronary artery disease, and the levels correlated with the number of lesions as well as the incidence of hypertension. F2-isoprostanes are highly concentrated in atherosclerotic plaques. Plasma F2-isoprostane correlated positively with systolic and diastolic blood pressure, supporting the role of oxidative stress in hypertension.
In terms of gut health, oxidative stress plays a significant role in the pathogenesis of various gastrointestinal diseases, including inflammatory bowel disease (IBD) and colorectal cancer. Elevated levels of F-2 Isoprostanes in the gut can indicate increased oxidative stress, which may contribute to inflammation and damage to the gut lining. This oxidative damage can disrupt the gut barrier, increasing intestinal permeability and further exacerbating inflammatory responses. Additionally, dietary interventions, such as the consumption of Brassica vegetables, have been shown to reduce urinary F-2 Isoprostane levels, suggesting that diet can modulate oxidative stress and potentially improve gut health.
Oxidative stress significantly contributes to gut dysbiosis and intestinal permeability, thereby contributing to various gastrointestinal and systemic diseases. Gut dysbiosis, an imbalance in the gut microbiome, can lead to the excessive production of reactive oxygen species (ROS). This increase in ROS results in inflammation, DNA damage, and activation of the immune system, which further exacerbates gut dysbiosis. The disruption of the gut microbiota’s balance impairs its ability to regulate oxidative stress, leading to a vicious cycle of increased oxidative damage and microbial imbalance.
Oxidative stress also affects intestinal permeability, often referred to as “leaky gut.” The intestinal barrier, composed of tight junctions between epithelial cells, is crucial for maintaining gut integrity and preventing harmful substances from entering the bloodstream. When oxidative stress disrupts these tight junctions by driving inflammation, it increases intestinal permeability, allowing endotoxins and other pathogens to pass through the gut lining into the systemic circulation. This breach in the intestinal barrier can trigger systemic inflammation and has been linked to the progression of various metabolic and autoimmune diseases.
Overall, the interplay among oxidative stress, gut dysbiosis, and intestinal permeability underscores the importance of maintaining a balanced gut microbiome and managing oxidative stress and the inflammatory response to preserve gut health and prevent disease.
F2-isoprostanes and 8-OHdG are elevated in cases of oxidative stress. Generally, treatments include nutritional support for detoxification, stimulation of the Nrf2-ARE pathway, antioxidants, minerals, adjunctive nutritional treatments, and elimination of toxins, infection, and environmental sources of oxidative stress. Females may have higher needs for antioxidants. Reducing BMI and stopping smoking can decrease oxidative stress by reducing the inflammatory response and toxic accumulation.
Nrf2 has been called the “master regulator” of the antioxidant response. Nrf2 is a transcription factor that regulates the expression of antioxidants and anti-inflammatory genes through the human Antioxidant Response Element (ARE). The Nrf2-ARE signaling pathway is the cell’s defense against oxidative stress and is triggered when free radicals increase and/or when there is reduced antioxidant capacity. Activation of the Nrf2-ARE pathway initiates the expression of genes encoding proteins involved in glutathione synthesis, Phase II detoxification, drug transport, ROS removal, reduction of inflammation, and protection against ischemia/reperfusion injury. The Nrf2-ARE signaling pathway upregulates SOD, GSH, and GPx, among others. For these reasons, targeting the Nrf2-ARE pathway with nutrients is a popular strategy to promote a person’s antioxidant defenses.
F-2 Isoprostanes serve as a crucial marker for evaluating oxidative stress and its impact on both systemic and gut health. Monitoring these levels can provide insights into the effectiveness of antioxidant therapies and dietary interventions aimed at reducing oxidative damage and improving overall health.